(Q37194205)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18562416%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

review article

1 reference

title

Limits of meta-analysis: methylphenidate in the treatment of adult attention-deficit hyperactivity disorder (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18562416%20AND%20SRC:MED&resulttype=core&format=json

attention deficit hyperactivity disorder

9 January 2020

main subject

0 references

0 references

1 reference

adult attention deficit hyperactivity disorder

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18562416%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

author name string

T Becker

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18562416%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

R Kilian

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18562416%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

J M Fegert

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18562416%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

S Weinmann

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18562416%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

language of work or name

English

0 references

publication date

18 June 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18562416%20AND%20SRC:MED&resulttype=core&format=json

Journal of Psychopharmacology

9 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18562416%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

volume

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18562416%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18562416%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

page(s)

733-744

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18562416%20AND%20SRC:MED&resulttype=core&format=json

The adult psychiatrist's dilemma: psychostimulant use in attention deficit/hyperactivity disorder

9 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0269881108092338

Inflation of the type I error rate when a continuous confounding variable is categorized in logistic regression analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108092338

Long-acting medications for the hyperkinetic disorders. A systematic review and European treatment guideline

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108092338

Development and validation of MIX: comprehensive free software for meta-analysis of causal research data

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108092338

Patterns of psychiatric comorbidity, cognition, and psychosocial functioning in adults with attention deficit hyperactivity disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108092338

A randomized, placebo-controlled trial of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108092338

Methylphenidate reduces impulsive behaviour in juvenile Wistar rats, but not in adult Wistar, SHR and WKY rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108092338

The Efficacy of 2 Different Dosages of Methylphenidate in Treating Adults with Attention-Deficit Hyperactivity Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108092338

A controlled trial of methylphenidate in adults with attention deficit/hyperactivity disorder and substance use disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108092338

Meta-analysis combining parallel and cross-over clinical trials. I: Continuous outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108092338

Meta-analysis combining parallel and cross-over clinical trials. III: The issue of carry-over

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108092338

Meta-analysis in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108092338

Evaluating meta-analyses in the general surgical literature: a critical appraisal

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108092338

Pharmacotherapy of adult ADHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108092338

Bias in location and selection of studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108092338

Meta-analysis of the efficacy of methylphenidate for treating adult attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108092338

Adjustment of meta-analyses on the basis of quality scores should be abandoned

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108092338

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108092338

The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108092338

Efficacy and safety of methylphenidate in 45 adults with attention-deficit/hyperactivity disorder. A randomized placebo-controlled double-blind cross-over trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108092338

Using metaanalysis to evaluate evidence: practical tips and traps.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108092338

Effects of chronic nicotine and methylphenidate in adults with attention deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108092338

Treatment of cocaine dependent treatment seekers with adult ADHD: double-blind comparison of methylphenidate and placebo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108092338

Treatment of methadone-maintained patients with adult ADHD: double-blind comparison of methylphenidate, bupropion and placebo

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108092338

Efficacy of stimulants in adult ADHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108092338

Methylphenidate effects on symptoms of attention deficit disorder in adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108092338

Combining effect size estimates in meta-analysis with repeated measures and independent-groups designs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108092338

Use of self-ratings in the assessment of symptoms of attention deficit hyperactivity disorder in adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108092338

Evidence-based guidelines for management of attention-deficit/hyperactivity disorder in adolescents in transition to adult services and in adults: recommendations from the British Association for Psychopharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108092338

The file drawer problem and tolerance for null results

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108092338

A large, double-blind, randomized clinical trial of methylphenidate in the treatment of adults with attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108092338

Efficacy and safety of dexmethylphenidate extended-release capsules in adults with attention-deficit/hyperactivity disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108092338

A double-blind, crossover comparison of methylphenidate and placebo in adults with childhood-onset attention-deficit hyperactivity disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108092338

A cognitive remediation programme for adults with Attention Deficit Hyperactivity Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108092338

An experimental comparison of Pycnogenol and methylphenidate in adults with Attention-Deficit/Hyperactivity Disorder (ADHD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108092338

A controlled study of methylphenidate in the treatment of attention deficit disorder, residual type, in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108092338

Drug Therapy for Adults with Attention-Deficit Hyperactivity Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108092338

Hyperactive night and day? Actigraphy studies in adult ADHD: a baseline comparison and the effect of methylphenidate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108092338

Does methylphenidate improve inhibition and other cognitive abilities in adults with childhood-onset ADHD?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108092338

A randomized, double-blind, crossover study of methylphenidate and lithium in adults with attention-deficit/hyperactivity disorder: preliminary findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108092338

Diagnosis and treatment of minimal brain dysfunction in adults: a preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108092338

21 January 2018

Identifiers

DOI

10.1177/0269881108092338

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18562416%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

1 reference